Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in Germany

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Medical device startups based in Germany. We rank investors based on the number of investments they made in Medical device companies from Germany. We update this investor list every month.

Top 50 Medical Device Startup Investors in Germany

Investor	Medical Device Germany investments
HTGF \| High-Tech Gruenderfonds	18
Bayern Kapital	8
KfW	7
NRW.BANK	5
TGFS - Technologiegründerfonds Sachsen	5
MIG Capital	5
bm-t beteiligungsmanagement thuringen	4
Brandenburg Kapital	4
Born2Grow	3
S-Venture Capital Dortmund	3
Think.Health	3
Playground Global	3
bmp Ventures	3
Expon Capital	3
IFB Innovationsstarter	3
Sparrow Ventures	3
Heal Capital	3
11k Ventures	3
BayBG Venture Capital	2
ES KAPITAL	2
b2venture (formerly btov Partners)	2
Green Park & Golf Ventures	2
Wellington Partners	2
HealthCap	2
APEX Ventures	2
AQAL Integral Investing	2
Lauder Partners	2
MassMutual Ventures	2
Atlantic Labs	2
Asabys Partners	2
TechVision Fund	2
Entrée Capital	2
Boehringer Ingelheim Venture Fund	2
Seed Fonds Aachen	2
Sofinnova Partners	2
DocCheck Guano AG	2
M-Invest	2
American RENOLIT Corporation	2
Brightlands Venture Partners	1
SeedCapital Dortmund	1
Pathena	1
RoX Health	1
Christoph Behn	1
Ancora Finance Group	1
Abiomed	1
Norgine Ventures	1
Ventegis Capital	1
BB Biotech Ventures	1
adesso ventures	1
Die Brückenköpfe	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Information Technology, Biotechnology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

Graswald — Graswald engages in the creation of natural and digital 3D worlds for the entertainment industry.
CustomSurg — RETHINKING TRAUMA SURGERY At CustomSurg we are changing the treatment of complex bone fractures from a subjective to an objective approach, through personalized solutions.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Funding Round
Germany, United States, Finland

Portfolio highlights

VITAS — Our system is based on Deep Learning and offers an intelligent voice assistant for customer service. Use cases can be found in both the SME and enterprise market for all companies with many standardized customer calls. VITAS answers the telephone, checks data in real time, can react flexibly to requests and offers the caller a self-service withoutwaiting time. Areas of application include restaurants, workshops, medical practices, taxi centres, insurance companies, banks and tax consultants.
BOX ID Systems — BOX ID Systems develops and offers an end-to-end location & process mining solution to cost effectively track millions of logistics assets digitally throughout the industrial supply chain across Europe and the World - including site-to-site, on-premises and indoor buildings digital twin of supply chain processes. The system is built on aspecialized analytics software platform, sensorik tracking devices and efficient data-, device- and user-management tools, including functions to support process automation and optimization. Industrial and automotive production customers benefit from making their logistics processes more efficient and cost optimized, with 100% transparency within their critical processes throughout the entire supply chain.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the LÃ¤nder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Series A, Series B
Germany, India, Kenya

Portfolio highlights

Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.

NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.

Investment focus

Biotechnology, Software, Information Technology
Seed, Series A, Series B
Germany, United States

Portfolio highlights

widu — widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace
bNear — bNear is the digital space for all distributed- & hybrid teams - Safe and convenient in Microsoft Teams!
Companyon Analytics — Companyon Analytics provides data security, cloud infrastructure, information technology, technical solutions, and consultancy services.

TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.

Investment focus

Software, Information Technology, Manufacturing
Seed, Funding Round, Series A
Germany, United States

Portfolio highlights

MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
volytica diagnostics — Our software enables customers to develop more economical battery systems, reduce operational risks and establish second-use concepts.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Funding Round, Series B
Germany, Austria, Canada

Portfolio highlights

AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability

bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
Germany, United States

Portfolio highlights

rooom.com — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
tediro — tediro develops a mobile robotics platform for multiple applications in healthcare primarily therapy and diagnostics
Coachwhisperer — Coachwhisperer offers smart intercom and monitoring system for coaches and athletes.

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Investment focus

Software, Health Care, Information Technology
Seed, Series A, Funding Round
Germany, United Kingdom

Portfolio highlights

Seqstant — Seqstant offers the LiveGene platform for real-time pathogen analysis, allowing for sensitive, specific, and user-friendly real-time genetic diagnostics.
IQONIC.AI — Creating AI Solutions for Skin, Hair & Inner Balance
Doctorflix — Doctorflix is a medical education platform that allows doctors around the globe to learn about methods of treatment while accelerating their system-required professional development. We are on a mission to build an engine that simplifies and democratizes the consumption and exchange of medical knowledge by interlinking doctors, hospitals, andpharmaceutical companies.

Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries

Investment focus

Software, Health Care, Medical Device
Seed, Series A, Series B
Germany, United States

Portfolio highlights

Semorai — Semorai - Intelligent error management for manufacturers We are reinventing the future of quality and error control in the industrial industry with our unique AI-as-a-Service solution.
Doinstruct — Doinstruct offers mobile training solution for frontline workers.
traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.

S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group.

Investment focus

Biotechnology, Guides, Genetics
Series B, Funding Round, Series A
Germany

Portfolio highlights

Innolume — Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallelfiber/waveguides, reducing short-reach system cost and power.
Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
Scienion — SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields â€“ from early research to manufacturing.

Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Series A, Series B
Germany, United States, Switzerland

Portfolio highlights

Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
Navignostics — Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey.At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancerdrug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development.Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners.This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.

Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.

Investment focus

Software, Robotics, Artificial Intelligence
Series A, Seed, Series B
United States, Canada, France

Portfolio highlights

Boxbot — Dynamic storage and retrieval platform that adapts to varying cubic dimensions and eliminates manual pick stations.
Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
Element Zero — Element Zero - The Green Metal Company. Element Zero has developed a novel approach to cost-effectively and efficiently convert metal ores such as iron ore, nickel ore and other future facing metals, to pure metal form with zero carbon emissions.

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Neotiv — Enabling cognitive health
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
InLine-Med — Radiologists perform safe, precise & easy interventions with the InLine-Med surgical tools and assistance devices.

Global investor in big ideas with the potential for positive impact & exponential growth

Investment focus

Software, E-Commerce, Information Technology
Series A, Seed, Series B
Luxembourg, France, United States

Portfolio highlights

Accelex — Accelex Technology, the technology solution to automate the acquisition, analysis and reporting of critical investment data. Learn more today.
MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
Videobot — Grow your business with personalised video funnels that engage your audience with human interaction, capture leads, guide your users, enhance customer satisfaction and increase conversion rate.Short videos have already become dominant across social media platforms. Now, this beloved user experience is available on company websites as well. The applications are vast and varied. Discover how it all works by reserving your own presentation slot.

The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Funding Round, Grant
Germany, United States

Portfolio highlights

3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
Stargazr — Stargazr is a AI-powered software that enables you to understand your financial data
Neuralfinity — Neuralfinity provides computer AI services. They generalise machine learning models by utilising an ML API as a service.

We are a Zurich-based Venture Builder and Growth Equity Investor. With our ambitious team of highly customer-focused entrepreneurs, we are committed to putting our expertise to work and strive to make an impact.

Investment focus

Health Care, Medical Device, Real Estate
Series A, Seed, Funding Round
Switzerland, Finland, Germany

Portfolio highlights

Properti — "building the world's greatest real estate company"Properti is a modern, young and pioneering PropTech startup founded in November 2019. Through our unique Properti System, which combines the latest technologies, in-depth expertise and world-class marketing, we provide an exclusive service. Our mission is to change the real estateindustry sustainably with the symbiosis of technology and people to build trustworthiness and transparency. Our goal is to offer customers a full service around the housing ecosystem.
HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
Selma Finance — With Selma you will get an investment plan that fits to your life and goals. Get started in minutes and let your money work for you.

Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.

Investment focus

Health Care, Artificial Intelligence, Machine Learning
Seed, Series A, Series B
Germany, Canada, Poland

Portfolio highlights

PeakData — PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area. PeakData is making sense of the data spread across the web by using the latest developments of AI.
Avi Medical — Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience.
Infermedica — Infermedica, a leading digital health company, tackles the problem of inappropriate use of medical services and misdiagnosis, providing insurance companies, hospitals, and health systems with a set of AI-powered preliminary diagnosis and triage solutions.“The broader goal is to improve customers’ performance, increase healthcare accessibility,and reduce costs. To date, our tools have been used by over 6 million users worldwide, and we are working with more than 50 companies, including Allianz Worldwide Partners, Microsoft, Global Excel, Médis, PZU Zdrowie, Sana Kliniken or Everyday Health,” says Piotr Orzechowski, Infermedica’s CEO.The company uses artificial intelligence and machine learning to assess symptoms and find patterns in data. Thanks to algorithms, Infermedica gets smarter over time. Additionally, the team of physicians verifies every piece of information that is added to the medical database to ensure that patients get safe and reliable recommendations. To date, physicians involved in the project have spent over 30,000 hours on reviews.Over the last year, Infermedica grew into a team of over 100 people, and its products were translated into 17 languages, making them available in countries such as China and the United Arab Emirates. The latest investment round of $10.25M will help to expand market presence in the United States and Europe, and accelerate the development of the technology.

We are a business angel collective based in Germany. We help early-stage startups that want to make a difference by preservation and improvement of human health.

Investment focus

Medical Device, Sensor, Medical
Seed, Convertible Note
Germany

Portfolio highlights

DeepSpin — DeepSpin is developing a next-gen, AI-powered MRI machine at a fraction of the cost, size and weight of standard systems, allowing to bring MRI to the point-of-care.
Mindpeak — Harnessing the power of Artificial Intelligence and machine learning, Mindpeak products can help make pathology diagnosis faster and more accurate.
atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.

Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Series B
Germany, Italy, United States

Portfolio highlights

4.screen — 4.screen is a technology company that develops technologies for driver interactions. The 4.screen Mobility Experience Cloud (MXC) connects the car to the mobility ecosystem and provides a standardized interface for real-time communication with drivers. 4.screen shares a common goal with car manufacturers and businesses – placing the driver at thecenter of every equation. Car manufacturers and mobility service providers implement 4.screen APIs into their existing systems and applications to provide integrated services for seamless journeys. Businesses of all sizes - from local shops to global brands - use 4.screen to communicate with drivers directly through the vehicle's screen. Drivers enjoy frictionless access to the mobility ecosystem, see more relevant content and benefit from value-added services such as sponsored parking and charging. The 4.screen technology is developed by a team of automotive, marketing, and software experts who are committed to creating seamless experiences for drivers.
ChargeOne — The complete charging solution for your e-mobility.
SUSHI Bikes — SUSHI Bikes has developed the perfect e-bike for modern urban people.

Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH

Investment focus

Software, EdTech, Medical
Seed, Pre-Seed, Series A
Germany

Portfolio highlights

Gyde — Gyde offers digital micro-learning and cross-company coaching for managers.
VISPA — Your virtual unlimited space for innovation projects, workshop facilitation, and agile meetings. With more than 30 available pre-built templates.
NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.

Investment focus

Software, Health Care, Information Technology
Series A, Seed, Series B
Germany, Switzerland, United Kingdom

Portfolio highlights

Yendou — We make it unbelievably easy, for clinical operations teams, to manage site selection activities for oncology clinical trials.
DUDE CHEM — DUDE CHEM is a leading company in green chemical manufacturing based in Berlin.
Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
United States, Israel, Sweden

Portfolio highlights

Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Germany, United States, United Kingdom

Portfolio highlights

Nosto — Smarter commerce experience management with AI-fueled personalization, merchandising, and site search
Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Pre-Seed
Germany, Austria, United Kingdom

Portfolio highlights

sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Pre-Seed
Germany, United States

Portfolio highlights

DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.

Lauder Partners, LLC is an entity investing in various realms of the technology field. Lauder invest both directly in companies as well as in funds - both venture and others. Since it primarily invests the capital of Gary Lauder and family members, we don't provide much information to the public.

Investment focus

Software, Internet, Health Care
Funding Round, Series B, Seed
United States, United Kingdom, China

Portfolio highlights

Lassen Peak — PUBLIC SAFETY INNOVATION Threat detection for a safer world Once in a great while, the path of advanced technology unexpectedly joins the basic needs of society. Learn More https://www.lassenpeak.com/wp-content/uploads/2023/12/Globe3.m4v Linkedin Envelope
OccamzRazor — OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.)and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.
NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.

Investment focus

Software, Financial Services, Information Technology
Series A, Series B, Seed
United States, India, Singapore

Portfolio highlights

XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
Qoala — Asuransi online yang siap melindungi kamu dan orang tersayang, di mana aja, kapan aja. Premi murah, proses klaim mudah, dan 100% digital!
Scrut Automation — Scrut Automation makes ISO 27001, SOC 2, GDPR and PCI DSS compliance easy, with 70% less Manual effort

Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.

Investment focus

Health Care, Software, Information Technology
Seed, Pre-Seed, Series A
Germany, Switzerland, United States

Portfolio highlights

Embea — Embea takes Embedded Insurance to Life & Health. Our easy-to-understand plans protect families against the most severe life risks of critical illnesses, accidents, and death. Companies of every size embed our simple and transparent insurance products into their apps and services. Embea removes complexity, paperwork, and pushy sales from theworld of life insurance. Our vision is a world where fair and affordable insurance is accessible to everyone.
Purpose Green — Purpose Green operates as a climatetech company.
150 Minuten — Das Startup 150Minuten aus Berlin möchte Menschen aller Alters- und Fitnessklassen für mehr Sport und Bewegung begeistern. Wir bieten ein modernes, interaktives Online-Kursangebot, an dem jede*r (direkt und live) von Zuhause aus teilnehmen kann.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Series B
Spain, Belgium, Germany

Portfolio highlights

Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
Gradient Denervation Technologies — Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension, based on prior research and intellectual property developed at Stanford University.

VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany

Investment focus

Software, Health Care, Artificial Intelligence
Seed, Pre-Seed, Series A
Germany, Spain

Portfolio highlights

Elevear — We develop breakthrough audio technologies for your hearables.
Membion — Membion provides wastewater treatment with membrane bioreactor technology.
Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.

We're a team of former serial founders managing over $1B across a number of funds, with offices in Tel Aviv, London, and New York.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Israel, United Kingdom

Portfolio highlights

Bujeti — Corporate Credit Cards, Spend Management software built for your African realities. It empowers your people to do more. It combines virtual, smart physical credit cards, payments and expenses into one experience powered by Visa Cards, dedicated NUBANs, Mobile Wallets and Faster Payments.
Finom — Finom is an online payment solution for companies and freelancers that helps entrepreneurs manage their finances. It's easy to use, secure, and covers all business needs.
Bluewhite — Blue White Robotics offers custom-made, on-time, and affordable testing and experiment solutions based on military experiment methodologies. It was established by a group of former Israeli Air Force pilots and engineers. BWR works in close cooperation with a variety of universities, vehicle manufacturers, and startups in Israel and worldwide.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Seed, Series A
Germany

Portfolio highlights

miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
Hemovent — Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.

Investment focus

Health Care, Medical Device, Mobile Apps
Seed, Funding Round, Pre-Seed
Germany, Spain, The Netherlands

Portfolio highlights

Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
medflex — Schaffen Sie echte Entlastung am Empfang mit intelligentem Telefonassistent, zentraler Anfragenverwaltung inklusive DSGVO-konformer medizinischer Messenger und digitalen Dokumenten. Jetzt mehr erfahren >
Mammoth Hunters — Mammoth Hunters is a 360° wellness solution offering accessible functional training, natural nutrition and lifestyle advice packaged as a mobile/web based SaaS. The founders come from a scientific background and use discoveries in human physiology and evolution to create personalized fitness journeys. The program is designed toeliminate all barriers that prevent people from leading a healthy lifestyle - lack of time, knowledge and motivation. The company employs 12+ people in Barcelona Spain and has key partnerships with fitness experts, healthcare companies, and sports technology companies.

M- Invest GmbH, Singen, Germany, represents the holding company for the business shares and stakes held by the Meder family.

Investment focus

Medical Device, Medical, Software
Series A
Germany

Portfolio highlights

CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
Capical GmbH — Capical is your partner for target-oriented, fast and sophisticated integration of monitoring solutions in your product. We work in the fields of research, development and productive applications for contact-free ECG measurement for more than 10 years. During that time, we have established Capical as the worldwide leader of the capacitive electrodetechnology.Our offer covers all stages of the development process. With the target to provide innovative and successful products in collaboration with you, we support you from building first prototypes up till serial production. Your benefit is our extensive know-how and experience from projects in various industry sectors.Capical has been awarded with the Fresenius Inventor Award, the IHK Technology Transfer Award and additional awards for its capability to transfer the capacitive technology in marketable products. It has been the first company worldwide which has medically approved an ECG-device based on capacitive electrodes and we are capable to defend your and our interests against competitors due to own important property rights.Join us with our target to establish the capacitive ECG measurement in various market segments to improve the quality of life of elderly or ill persons as well as improve safety and comfort in the increasing segment of automated driving.

With decorative, high-quality and sustainable plastic products, we create clear added value for our customers and improve the quality of life.

Investment focus

Health Care, Medical Device, 3D Printing
Series A
Germany

Portfolio highlights

Kumovis — The EXT 220 MED, formerly the Kumovis R1, is the only extrusion platform that features an integrated clean room and is validated by leading medical device manufacturers and hospitals worldwide.
Inovedis — The SINEFIX Implant System is an easy-to-learn solution aimed at simplifying rotator cuff repair procedures and improving patient outcomes.

Dit is de Kitchensink.

Investment focus

Biotechnology, Medical Device, Health Care
Seed, Series A, Funding Round
The Netherlands, Germany

Portfolio highlights

Circularise — Circularise brings transparency to global supply chains. Circularise offers different solutions for different problems within the supply chain. Learn how you can become part of the Circular Economy and what solution Circularise can offer your company.
Corporis Medical — Corporis Medical is a start up focussing on the development and commercialization of innovative medical devices that improve outcomes of surgical interventions. Formerly known as Health Value Creation.
ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.

SeedCapital Dortmund GmbH & Co. KG is the right partner. They participate in innovative, technology-oriented companies in the start-up or early stage companies. And yet retain independence. Because when they are holding "only" partner on time. Together they participate in the appreciation and therefore the success of company.

Investment focus

Information Technology, Enterprise Software, Software
Seed, Series A, Funding Round
Germany, United States

Portfolio highlights

ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
pickshare — pickshare is a logistics platform for large retailers and brands.
Volterion — Volterion was founded in 2015 as a spin-off of the Fraunhofer Institute UMSICHT.Right from the start, they put their energy into the development of the stack – the energy converter of a redox flow battery and thus the basis for an efficient system.After extensive development work, they now produce their stacks using a unique manufacturingprocess that they are constantly improving.On this basis, they also develop innovative energy systems such as the powerRFB. A scalable battery in a compact housing that meets the highest industrial demands and is used in many different applications.Sascha Berthold, Thomas Gebauer and Thorsten Seipp are the founders of the company and have been involved in the development of Volterion technology. Together with Kees van de Kerk they form the management today.Volterion has received many awards for its technology and business model, including the ACHEMA Energy Founders Award, the TU Startup Award, the KUER Growing Business Award and the Best Pitches Award.

Pathena is an investment firm engaged on boosting the success of information technology and digital biomedical companies.

Investment focus

B2B, Made to Order, Marketing
Series A, Seed, Series C
Portugal, Germany

Portfolio highlights

BIZAY / 360imprimir — • Bizay has empowered more than 1 Million SMB’s to grow their businesses during the last 5 years.• Bizay is a tech-based B2B Marketplace for made-to-order products. Running a fabless business model (no capex), it leverages on the idle capacity of production partners to meet the needs of the SMB’s.• Started on printing, packaging, textile andprofessional products and now applying the same model in furniture, food and 3D printing (amongst others).• 360imprimir / 360onlineprint - rebranded to Bizay - Your bussiness your way - to reflect the unlimited product categories. • Bizay is the customer facing brand (the SMB’s do not meet the production partners) and its tech platform manages the production by: o Using data and algorithms to aggregate different orders and to decide in which suppliers to produce them, driving huge efficiency and speed gains. o Enabling full tracking of the orders in the different production partners and automating pre-production processes.• Bizay differentiates themselves from other players by offering: o Online configuration of the products (options to customize and personalize). o Competitive pricing for small and medium orders (similar price per unit as for large orders), 48 hours of delivery time (instead of several weeks) and guaranteed quality (customer-facing brand ensuring high quality levels). o Integrated value chain in a single offer (on-demand design services provided by external providers).• Originally selling in Portugal, Spain, Brazil and México, the company raised B round of 18m€ one year ago (communicated in April) in order to launch new countries.• 17 new countries were launched in 2019 simultaneously (including DE, FR, UK and USA).• In 2019, 8 months of trading in the new countries confirm: o Competitiveness pricing of their offer in all the market. o Market deepness and sound acquisition metrics.
Promptly — Health Analytics Patient Report Outcomes, Health Care, Value based health
NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.

Hello, our name is ROXand we are taking digital healthcare to the streets.

Investment focus

Health Care, Health Diagnostics, Apps
Pre-Seed, Seed
Germany, Austria

Portfolio highlights

XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
MindAhead — Digital Health, Med Tech, Brain Health

Christoph Behn is the Chairman & Founder of better ventures. He previously worked at Die Kartenmacherei as an Advisory Board & Founder. Christoph Behn attended HHL Leipzig Graduate School of Management.

Investment focus

Software, Advanced Materials, Manufacturing
Pre-Seed, Seed, Funding Round
Germany

Portfolio highlights

42 Watt — 42 Watt is an energy conservation consultancy which strives to reduce costs, save energy and protect the climate.
Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
Strollme — Strollme believes in idea of using resources wisely, they started with stroller which can be reused for next time.

Ancora Finance Group is an international management consulting firm that offers unparalleled leadership, strategic, and operational advice. Their focus on financial services is deeply rooted in the DNA of their company as it comes from their people. They are based in London and Singapore, providing unparalleled leadership, strategic andoperational solutions for the financial services industry. Their experience, expertise, and approach combine consulting and knowledge transfer.

Investment focus

Medical, Medical Device, Health Care
Series A
Spain, Germany

Portfolio highlights

Koa Health — Partner with Koa Health to deliver mental healthcare to those employees who need therapy, and the up to 75% of your workforce who prefer to access support on their own terms. With a prevention-first approach to personalized, precision care, Koa Care 360 lowers barriers to entry with easy access to human and digital support across the full continuum of mental health. It includes:
Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's productsare used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Investment focus

Medical Device, Health Care, Medical
Series B, Series D, Funding Round
United States, Germany, Israel

Portfolio highlights

Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
Impulse Dynamics — Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediateand powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
Shockwave Medical — Shockwave Medical is a Cardiovascular Medical Device Company changing how calcified cardiovascular disease is treated with Intravascular Lithotripsy (IVL).

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Debt Financing, Series A
France, United Kingdom, United States

Portfolio highlights

ImaginAb — ImaginAb is a pioneering biotech company, innovating for tomorrow with modern radiopharmaceutical advances. Our advanced imaging solutions like CD8 ImmunoPET are aimed to accelerate the progress of physicians all over the world, ending the need for repeat, painful biopsies.
PathoQuest — PathoQuest provides a pioneering next generation sequencing (NGS) approach to biologics characterization and release testing
Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.

The Ventegis Capital AG in 2001 emerged from the merger of the Berlin AG Beteiligungsgesellschaft effect on the Cybermind AG. Both companies have been in private equity / venture capital activity. As a publicly traded venture capital company, they invest the money of their shareholders. The activities of the Ventegis are divided into twobusiness segments. In addition to the venture capital business since 2002 consulting services offered. In the venture capital business Ventegis belongs to the smaller players on the German market. As a reliable and active partner, they position themselves as a typical lead-as well as co-investors. Here they prefer to consortia consisting of renditeorientieren and strategic investors. In future, the market position through further Neuinvestments expanded. Crucial for a commitment of Ventegis are the yield potentials of our investments, which in the past the focus of investment activity on early-stage financing traditionally stood.

Investment focus

Manufacturing, Audio, Test and Measurement
Funding Round, Series A, Series B
Germany

Portfolio highlights

AUPEO! — AUPEO! is the provider of personalized audio streams for internet-capable hardware devices and offers radio stations that compile an individual music program for users and recommend songs to them. The recommendation technology is based on an algorithm from the Fraunhofer Institute, inventors of the MP3 format. AUPEO! works together with numeroustier 1 manufacturers of internet-capable audio devices and can be found on the web at www.aupeo.com, as iPhone/ iPad and Android app as well as being available on Netbooks, Connected TVs, nearly all Webradio devices and many Smartphones. Partners include Acer, ASUS, MINI, Philips and Loewe, among others.
Humedics — Humedics, based in Berlin, focuses on rapid and precise liver function measurement using LiMAx, its innovative breath analysis technology. This easy-to-use bedside test provides doctors with accurate information to support decision making in tailoring the medical treatment to the individual level of each patient and to improve patient outcomes.LiMAx has already been used on thousands of patients and the company is currently expanding its operation globally.
Nanda Technologies — Nanda Technologies was founded in 2006 in Munich. They are an international team of experienced engineers and managers from the semiconductor/high-tech industry. They are in the process of bringing their new product to the market by working together with selected lead customers.

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernseyâ€“based fund is advised by the Bellevue Asset Management Group, which has operations in CuraÃ§ao, Boston/USA and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES has a dedicated teamof investment advisors and an advisory board. In addition, it is supported by all of the Groupâ€™s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.

Investment focus

Biotechnology, Health Care, Medical
Series C, Series A, Funding Round
United States, Switzerland, Italy

Portfolio highlights

Arvinas — Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Aleva Neurotherapeutics — Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity,translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor.To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage.Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use.Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.

Der Inkubator der adesso Group - Was du brauchst und was wir dir bieten.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
Germany

Portfolio highlights

Hanko — Hanko offers the complete developer toolkit for passwordless identities and multi-factor authentication. Cloud-native. Scalable. Secure.
TamedAI — We harness the power of large language models and the latest computer vision techniques to extract and process documents and semantic content.
Nia Health — Nia Health | Innovating Medical Technology

Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.

Investment focus

Artificial Intelligence, Health Care, Life Science
Seed, Series A, Pre-Seed
Germany, Austria

Portfolio highlights

anvajo — Originally started at TU Dresden, anvajo can now look back on several years of innovative research and successful product development with uninterrupted growth. As part of the business expansion and ongoing team building, anvajo moved into its new headquarters in Dresden in January 2020. On 1300 m² practically all areas, including development,production and support functions are united under one roof.
keleya — Keleya enables women and their partners to have a safe and relaxed pregnancy, birth experience and motherhood by providing them with personalized, expert based information, workouts and nutrition plans and a matching midwife. Founded in 2017, Kelaya is headquartered in Berlin, Germany.
Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate